Kraig Biocraft Laboratories Completes Phase One of its Spider Silk Production Facility Expansion


ANN ARBOR, Mich., July 15, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces today the completion of phase one construction for its production facility expansion. This project was completed on budget and on schedule. This facility is now ready to support the Company's third production wave, which will begin this month.

This additional production space will allow Kraig Labs to continue its production expansion during the rainy season when silk production is traditionally reduced. This new space provides the facilities for the Company to process, dry, and store fresh mulberry needed during the rainy season. With this new space, the Company can continue expanding its spider silk production.

Kraig Labs is also investing in a second, significantly larger project, constructing a new dedicated silkworm egg hatchery. This larger facility is expected to address the Company's production needs for the next 12-18 months. Construction on this project is also underway. It is expected to be online before the end of the rainy season.

"These investments in production capacity expansion are a part of our systematic growth plan for commercial scale production of spider silk," said the Company’s Founder and CEO, Kim Thompson. "These additional facilities will allow us to keep our foot on the accelerator, bringing cost-effective and eco-responsible spider silk to the global markets."

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC
(720) 288-8495
ir@KraigLabs.com